Controlling the pandemic during the SARS-CoV-2 vaccination rollout

被引:0
|
作者
João Viana
Christiaan H. van Dorp
Ana Nunes
Manuel C. Gomes
Michiel van Boven
Mirjam E. Kretzschmar
Marc Veldhoen
Ganna Rozhnova
机构
[1] University Medical Center Utrecht,Julius Center for Health Sciences and Primary Care
[2] Utrecht University,Faculdade de Ciências
[3] Universidade de Lisboa,Theoretical Biology and Biophysics (T
[4] Los Alamos National Laboratory,6)
[5] Universidade de Lisboa,BioISI—Biosystems & Integrative Sciences Institute, Faculdade de Ciências
[6] Universidade de Lisboa,Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
There is a consensus that mass vaccination against SARS-CoV-2 will ultimately end the COVID-19 pandemic. However, it is not clear when and which control measures can be relaxed during the rollout of vaccination programmes. We investigate relaxation scenarios using an age-structured transmission model that has been fitted to age-specific seroprevalence data, hospital admissions, and projected vaccination coverage for Portugal. Our analyses suggest that the pressing need to restart socioeconomic activities could lead to new pandemic waves, and that substantial control efforts prove necessary throughout 2021. Using knowledge on control measures introduced in 2020, we anticipate that relaxing measures completely or to the extent as in autumn 2020 could launch a wave starting in April 2021. Additional waves could be prevented altogether if measures are relaxed as in summer 2020 or in a step-wise manner throughout 2021. We discuss at which point the control of COVID-19 would be achieved for each scenario.
引用
收藏
相关论文
共 50 条
  • [1] Controlling the pandemic during the SARS-CoV-2 vaccination rollout
    Viana, Joao
    van Dorp, Christiaan H.
    Nunes, Ana
    Gomes, Manuel C.
    van Boven, Michiel
    Kretzschmar, Mirjam E.
    Veldhoen, Marc
    Rozhnova, Ganna
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [3] Vaccination Beliefs and Attitudes of Lactating People During the SARS-CoV-2 Pandemic
    Mark, Elyse G.
    Demirci, Jill R.
    Megli, Christina
    Martin, Judith M.
    Rick, Anne-Marie
    [J]. JOURNAL OF HUMAN LACTATION, 2023, 39 (03) : 415 - 425
  • [4] EPIDEMIOLOGICAL FRAMEWORK OF MYOCARDITIS DURING SARS-COV-2 PANDEMIC AND VACCINATION CAMPAIGN
    Bonini, J.
    Dal Passo, B.
    Vitagliano, A.
    Bugani, G.
    Pallotti, M.
    Casella, G.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26
  • [5] Research during the SARS-CoV-2 pandemic
    Munoz de Nova, Jose Luis
    Ortega-Gomez, Mara
    Abad-Santos, Francisco
    [J]. MEDICINA CLINICA, 2021, 156 (01): : 39 - 40
  • [6] Vaccination against SARS-CoV-2 during pregnancy
    Dalcin, Daniel
    Halperin, Scott A.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2024, 196 (02) : E59 - E60
  • [7] Kawasaki Disease During the SARS-CoV-2 Pandemic
    Goyal, Anisha
    Maheshwari, Anu
    Shakeel, Adiba
    Saneja, Vipul
    Kumar, Sarvesh
    Mahto, Deonath
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2022, 89 (11): : 1157 - 1157
  • [8] Critical Operations During the SARS-CoV-2 Pandemic
    Karaca, Olga
    Rueggeberg, Joerg-Andreas
    Bialas, Enno
    Schuster, Martin
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 119 (33-34): : 558 - 559
  • [9] Management of Anaphylaxis During the SARS-CoV-2 Pandemic
    Kanwaljit K. Brar
    Albana Harizaj
    Anna Nowak-Wegrzyn
    [J]. Current Treatment Options in Allergy, 2021, 8 : 88 - 96
  • [10] Sports Health During the SARS-Cov-2 Pandemic
    Timpka, Toomas
    [J]. SPORTS MEDICINE, 2020, 50 (08) : 1413 - 1416